IT — Gartner, Inc.

Sentiment is genuinely mixed. The bear case dominated the first half of 2026 (stock down >24% YTD) on flat-to-negative reported revenue and fears that enterprise GenAI tools will substitute for paid research seats. That flipped hard on 2026-08-04: Q2 2026 revenue of $1.68B beat by ~$50M, adjusted EPS of $4.37 beat by $0.64, management raised FY2026 adjusted EPS guidance to at least $14.00, and the company repurchased 3.6M shares for $547M in the quarter — the stock ran ~31.2% in August. But sell-side conviction has not followed: the consensus rating is Hold (5 buy / 10 hold / 3 sell per FMP), and the average 12-month target sits at $172.50 (FMP) to ~$185 (brief), i.e., essentially at or barely above the 2026-09-13 price of $179.59. A recent 1-week return of -3.66% with the price 4.48% below its 20-day SMA shows the August momentum is already cooling.

The top line has stalled while the bottom line is still compounding — an unusual and important split. Revenue went from $6.27B in FY2024 to $6.50B in FY2025 (+3.7%), and TTM through 2026-06-30 is $6.46B, essentially flat. Worse, the two most recent reported quarters were negative year-over-year: Q1 2026 revenue of $1,511.0M (-1.5% vs $1,534.1M) and Q2 2026 revenue of $1,675.9M (-0.6% vs $1,686.5M), although Q2 2026 was +2.8% on an adjusted basis excluding divested operations. Margins are the opposite story and clearly inflecting upward: Q2 2026 operating margin was 22.6% versus 19.4% a year earlier (+320bp), and Q1 2026 was 20.9% versus 18.1% (+280bp). GAAP EPS tells a cleaner story on an adjusted basis than on a reported one — Q2 2026 GAAP EPS of $4.14 (+33% y/y) and adjusted EPS of $4.37, Q1 2026 EPS of $3.18 (+17% y/y) — but the four-quarter window is contaminated: Q3 2025 operating income collapsed to $86.3M (5.7% margin) from $245.8M (16.6%) a year earlier on comparable revenue, and Q3/Q4 2024 GAAP EPS of $5.32 and $5.11 were inflated by non-operating gains (net income exceeded operating income in both quarters). Read through the noise: this is a decelerating revenue story with genuine, sustained margin expansion and double-digit EPS growth — not yet a structural revenue decline, but no longer a growth company either. Note also that TTM free cash flow of $1,289M is down 14.7% from $1,512M a year earlier, though H1 2026 FCF of $749M is up 17.9% y/y, so the decline is concentrated in the distorted H2 2025 period.

Cheap versus its own history, and cheap in absolute terms — with one honest caveat. As of 2026-09-13, the trailing P/E of 16.1x is roughly half the 5-year average of 33.1x, and P/S of 1.86x is roughly a third of the 5-year average of 5.15x. On forward numbers the gap widens further: $179.59 against FY2026 consensus EPS of $14.466 is ~12.4x, and against management's guided floor of $14.00 it is 12.8x. EV/EBITDA is 10.3x per the ratio screener, and TTM FCF of $1,289M against a $12.02B market cap is a 10.7% FCF yield (EV of ~$13.5B against FCF is ~10.5x). The PEG ratio of -0.507 is meaningless here because trailing growth is distorted and near zero. Two data caveats: price-to-book of -71.4x and debt-to-equity of -17.8x are artifacts of negative stockholders' equity (-$167M at 2026-06-30) and carry no information; and the 5.85% dividend yield in the feed is almost certainly a data error, since Gartner returns capital via buybacks (3.6M shares for $547M in Q2 2026 alone), not dividends. The valuation is only defensible cheap if revenue stops being negative — if the top line keeps declining, 12.4x forward is the correct multiple, not a discount.

The market is pricing Gartner for stagnation, and the Q2 2026 print challenged that. Consensus for Q2 was roughly $1.63B of revenue and $3.73 of adjusted EPS; Gartner delivered $1.68B and $4.37, a $50M revenue beat and a $0.64 EPS beat, then raised full-year guidance. If the adjusted +2.8% revenue growth and stable margins hold, the stock is being asked to carry a ~12.4x forward multiple on a business that should command 15–16x, which implies a re-rating toward $215–230 with no change in fundamentals. If, instead, reported revenue stays negative and Contract Value growth keeps decelerating, the current multiple is fair and the only return driver is the buyback — roughly 4–5% of shares retired per quarter at recent pace, which mechanically supports high-single-digit EPS growth without any re-rating. The single number that resolves this is Contract Value growth disclosed in the Q3 2026 report (late October/early November 2026); until then, you are being paid a 10%+ FCF yield to wait.

As of 2026-09-13, RSI(14) was 49.25 — dead neutral, no oversold or overbought signal. The price of $179.59 sat 4.48% below its 20-day SMA (~$188), but 7.45% above its 50-day SMA (~$167) and 1.75% above its 200-day SMA (~$176.50), so the short-term pullback is a consolidation after the August spike, not a trend break. Momentum history: -3.66% over 1 week, +0.07% over 1 month, +21.21% over 3 months, +7.71% over 6 months — the stock has already run hard off its April low. Entry-timing implication: there is no urgency to chase at $179.59. The $167–$176 zone (50-day and 200-day) is a more attractive risk/reward reference, and with a 52-week range of $124.25–$265.85 — a 114% spread — position sizing matters more than timing here. A close below the 200-day would undermine the August recovery thesis.

• The AI paradox: enterprise IT spending is forecast by Gartner itself to grow 14.2% in 2026 to $6.37 trillion, but that growth is concentrated in data-center and AI infrastructure, not research advisory seats — Gartner's own end market sees little direct benefit, while the same GenAI tools are the credible long-term substitute for the advice it sells.
• Discount rates and leverage: with $2.98B of long-term debt against $1.49B of cash, negative stockholders' equity, and a current ratio of 0.88, Gartner is a levered long-duration cash-flow asset. Higher-for-longer rates pressure both the multiple and refinancing costs; rate cuts would be a direct tailwind to both.
• Corporate budget scrutiny: elevated cost-prioritization is creating friction on high-ticket multi-year subscription renewals, which is the mechanism behind decelerating Contract Value growth.
• Currency: Gartner generates a substantial share of revenue outside the US, so dollar strength is a real drag on as-reported revenue and is a plausible partial explanation for the -0.6% and -1.5% reported growth in Q2 and Q1 2026 versus the +2.8% adjusted figure.
• Sector rotation: after the 2026 drawdown, Gartner sits in the 'cheap, high-FCF, out-of-favor tech' bucket. Money rotating out of AI infrastructure winners into de-rated cash compounders is a real, if unquantifiable, tailwind.

• Q3 2026 earnings (historically late October / early November 2026) — the first hard read on Contract Value growth and whether reported revenue turns positive; this is the single biggest swing factor for the multiple.
• Continued buyback execution — 3.6M shares repurchased for $547M in Q2 2026 alone (~5% of shares outstanding); if repeated, the share count could fall another 4–5% by mid-2027, mechanically lifting EPS.
• The inaugural Enterprise Risk, Audit & Compliance Conference in London on 2026-09-28/29 — a soft leading indicator on demand for AI-governance advisory and whether Gartner can monetize the AI transition rather than be disrupted by it.
• FY2027 guidance and outlook, likely in February 2027 — a clean, non-distorted read on the underlying growth algorithm once the Q3 2025 one-off charge rolls out of the comparison base.
• Any further portfolio moves — the 'adjusted excluding divested operations' language in Q2 2026 implies recent divestitures, and additional dispositions could sharpen the growth profile or fund more buybacks.

• Structural AI substitution: enterprise GenAI tools performing internal technology planning and vendor evaluation could erode both renewal rates and pricing power on Gartner's core research seats — a slow-burn threat to the wide-moat thesis, not just a growth problem.
• Contract Value growth keeps decelerating. Reported revenue has already been flat-to-negative for two consecutive quarters (-0.6% and -1.5%); if that becomes the trend rather than a divestiture/FX artifact, the 12.4x forward multiple is not cheap, it is accurate.
• Balance sheet fragility: negative stockholders' equity of -$167M at 2026-06-30, $2.98B of long-term debt against $1.49B of cash, and a current ratio of 0.88. Buybacks funded partly with debt leave less flexibility if free cash flow turns down.
• Free cash flow trend is not clean: TTM FCF fell 14.7% year-over-year to $1,289M, and while H1 2026 FCF rose 17.9%, the decline overlaps a poorly explained one-off charge in Q3 2025 (operating margin of 5.7% vs 16.6% a year earlier). Persistent reporting noise makes the true earnings power hard to pin down.
• Extreme volatility and thin analyst conviction: a 52-week range of $124.25–$265.85 (~114%) and a rating mix of 5 buy / 10 hold / 3 sell means the stock can move violently on a single Contract Value datapoint, in either direction.
• Capital return dependence: with revenue growth near zero, a large share of future EPS growth depends on sustaining $500M+ quarterly buybacks and on debt markets continuing to accommodate them.

Gartner is a genuinely high-quality asset — 68.9% gross margins, 18.8% ROIC, an asset-light subscription model, and a -1.71% accruals ratio showing cash earnings running ahead of reported profit — currently priced at ~12.4x forward EPS and a ~10.7% trailing FCF yield, as if the top line were in permanent decline. The 2026-08-04 Q2 print suggests that fear overshot: adjusted revenue +2.8%, adjusted EPS of $4.37 (a $0.64 beat), raised guidance, and roughly 300bp of year-over-year operating-margin expansion in both of the last two quarters. But reported revenue is still negative, Contract Value growth is unverified until the Q3 report, and the AI-substitution question is real and unresolved, so this is a 'cheap only if growth stops being negative' situation — an attractive risk/reward for a patient investor with a wide margin of safety, not a slam dunk.

Forward P/E applied to a two-year earnings bridge, cross-checked on free cash flow. I use FY2026E adjusted EPS of $14.30 (management guidance floor of $14.00, consensus $14.466, Q2 beat and raise) grown ~8% to FY2027E EPS of $15.45 on roughly 3% revenue, modest margin expansion, and ~4% annual share-count reduction, then apply 15.5x — a deliberate discount to the ~20x norm for wide-moat information-services compounders to reflect the flat reported top line and the unresolved AI-substitution risk, but a premium to the current 12.4x forward multiple, which prices in outright stagnation. That yields $239. Cross-check: at $239, equity value is $16.0B and EV (adding $2.98B debt, subtracting $1.49B cash) is ~$17.5B, or about 13x my FY2026E free cash flow of ~$1.34B — a reasonable price for a 69%-gross-margin, 18.8%-ROIC subscription business.